Basic Study
Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer
World J Clin Oncol
7(6):425-432.
Published online Dec 10, 2016.
doi: 10.5306/wjco.v7.i6.425
Abstract (1481)
|
Core Tip (1269)
|
Full Article (HTML) (4025)
|
Figures (1-2) (554)
|
Tables (1-2) (492)
|
Full Article (PDF)-2061K (514)
|
Audio-594K (65)
|
Peer-Review Report-120K (296)
|
Answering Reviewers-141K (343)
|
Received: 06/20/2016
|
Revised: 08/12/2016
|
Accepted: 10/27/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (15078)
|
Similar Articles (102)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Clin Oncol
7(6):433-440.
Published online Dec 10, 2016.
doi: 10.5306/wjco.v7.i6.433
Abstract (1454)
|
Core Tip (1410)
|
Full Article (HTML) (4409)
|
Figures (1-3) (1002)
|
Tables (1-2) (590)
|
Full Article (PDF)-1143K (563)
|
Audio-1781K (31)
|
Peer-Review Report-120K (310)
|
Answering Reviewers-566K (391)
|
Received: 08/03/2016
|
Revised: 09/10/2016
|
Accepted: 10/18/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (18568)
|
Similar Articles (1088)
|
Timeline of Article Publication (0)
|
Authors Evaluation (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
